中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

自身免疫性肝炎与原发性胆汁性胆管炎临床特征比较

舒艳芸 潘晓莉 宋宇虎 叶进

引用本文:
Citation:

自身免疫性肝炎与原发性胆汁性胆管炎临床特征比较

DOI: 10.3969/j.issn.1001-5256.2019.02.022
详细信息
  • 中图分类号: R575

Clinical features of autoimmune hepatitis and primary biliary cholangitis: A comparative analysis

  • 摘要:

    目的比较自身免疫性肝炎(AIH)、原发性胆汁性胆管炎(PBC)临床特征,以利于两者的鉴别及早期诊断。方法收集2010年1月-2018年2月华中科技大学同济医学院附属协和医院诊治的AIH患者(n=83)和PBC患者(n=108)临床资料,包括年龄、性别、血清生化、免疫学指标及肝脏病理学检查结果,比较AIH与PBC的不同特征。正态分布计量资料两组间比较采用独立样本t检验;偏态分布计量资料两组间比较采用Mann-Whitney U检验。计数资料两组间比较采用X2检验或Fisher确切概率法。结果纳入AIH及PBC患者均以女性为主,发病年龄高峰为40~60岁。二者临床表现无明显特异性,主要症状体征均为:乏力、腹胀、黄疸、纳差,其中AIH组纳差患者比例明显高于PBC组(25%vs 14%,X2=6. 52,P=0. 011)。此外,AIH组肝硬化及合并风湿性疾病的比例亦明显高于PBC组(59. 0%vs 40. 7%,X2=6. 23,P=0. 012; 23. 5%vs 15. 7%,X2=7. 46,P=...

     

  • [1]GATSELIS NK, ZACHOU K, KOUKOULIS GK, et al.Autoimmune hepatitis, one disease with many faces:Etiopathogenetic, clinico-laboratory and histological characteristics[J].World J Gastroenterol, 2015, 21 (1) :60-83.
    [2]LIU YW, YANG S, CEHNG J.Extrahepatic autoimmune diseases in primary biliary cholangitis[J/CD].Chin J Liver Dis:Electr Version, 2017, 9 (4) :27-30. (in Chinese) 刘雨薇, 杨松, 成军.原发性胆汁性胆管炎合并肝外自身免疫性疾病研究进展[J/CD].中国肝脏病杂志:电子版, 2017, 9 (4) :27-30.
    [3]HENNES EM, ZENIYA M, CZAJA AJ, et al.Simplified criteria for the diagnosis of autoimmune hepatitis[J].Hepatology, 2008, 48 (1) :169-176.
    [4]QIU D, WANG Q, WANG H, et al.Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients[J].J Hepatol, 2011, 54 (2) :340-347.
    [5]HEATHCOTE EJ.Management of primary biliary cirrhosis.The American Association for the Study of Liver Diseases practice guidelines[J].Hepatology, 2000, 31 (4) :1005-1013.
    [6]LINDOR KD, GERSHWIN ME, POUPON R, et al.Primary biliary cirrhosis[J].Hepatology, 2009, 50 (1) :291-308.
    [7]European Association for the Study of the Liver.EASL clinical practice guidelines:Management of cholestatic liver diseases[J].J Hepatol, 2009, 51 (2) :237-267.
    [8]Chinese Society of Infectious Diseases and Parasitology and Chinese Society of Hepatology of Chinese Medical Association.The programme of prevention and cure for viral hepatitis[J].Chin J Infect Dis, 2001, 19 (1) :56-62. (in Chinese) 中华医学会传染病与寄生虫病学分会、肝病学分会.病毒性肝炎防治方案[J].中华传染病杂志, 2001, 19 (1) :56-62.
    [9]GORDON V, ADHIKARY R, APPLEBY V, et al.Diagnosis, presentation and initial severity of Autoimmune Hepatitis (AIH) in patients attending 28 hospitals in the UK[J].Liver Int, 2018, 38 (9) :1686-1695.
    [10]CORPECHOT C, CHAZOUILLRES O, ROUSSEAU A, et al.A placebo-controlled trial of bezafibrate in primary biliary cholangitis[J].N Engl J Med, 2018, 378 (23) :2171-2181.
    [11]Chinese Society of Hepatology, Chinese Medical Association;Chinese Society of Gastroenterology, Chinese Medical Association;Chinese Society of Infectious Diseases, Chinese Medical Association.Consensus on the diagnosis and management of primary biliary cirrhosis (cholangitis) (2015) [J].J Clin Hepatol, 2015, 31 (12) :1980-1988. (in Chinese) 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会.原发性胆汁性肝硬化 (又名原发性胆汁性胆管炎) 诊断和治疗共识 (2015) [J].临床肝胆病杂志, 2015, 31 (12) :1980-1988.
    [12]GRANITO A, MURATORI P, MURATORI L, et al.Antinuclear antibodies giving the'multiple nuclear dots'or the'rim-like/membranous'patterns:Diagnostic accuracy for primary biliary cirrhosis[J].Aliment Pharmacol Ther, 2006, 24 (11-12) :1575-1583.
    [13]CHEN Y, HAN Y.Clinical features of primary biliary cholangitis and stratified treatment management[J].J Clin Hepatol, 2017, 33 (11) :2095-2100. (in Chinese) 陈瑜, 韩英.原发性胆汁性胆管炎的临床特征与治疗分层管理[J].临床肝胆病杂志, 2017, 33 (11) :2095-2100.
    [14]HE LF, LAI YJ, LAI LY, et al.Clinical features of patients with primary biliary cirrhosis[J].J Cent South Univ:Med Sci, 2015, 40 (12) :1333-1339. (in Chinese) 何丽芬, 赖伊杰, 赖力英, 等.原发性胆汁性肝硬化的临床特点[J].中南大学学报:医学版, 2015, 40 (12) :1333-1339.
    [15]JIANG XH, ZHONG RQ, YU SQ, et al.Construction and expression of a humanized M2 autoantigen trimer and its application in the diagnosis of primary biliary cirrhosis[J].World JGastroenterol, 2003, 9 (6) :1352-1355.
    [16]DUAN WJ, OU XJ, MA H, et al.Diagnostic value and clinical significance of anti-sp100 and anti-gp210 in patients with primary biliary cholangitis[J].J Clin Exp Med, 2018, 17 (15) :1579-1581. (in Chinese) 段维佳, 欧晓娟, 马红, 等.抗sp100和抗gp210在原发性胆汁性胆管炎中的诊断和临床意义[J].临床和实验医学杂志, 2018, 17 (15) :1579-1581.
    [17]Chinese Society of Hepatology, Chinese Medical Association;Chinese Society of Gastroenterology, Chinese Medical Association;Chinese Society of Infectious Diseases, Chinese Medical Association.Consensus on the diagnosis and management of autoimmune hepatitis (2015) [J].J Clin Hepatol, 2016, 32 (1) :9-22. (in Chinese) 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会.自身免疫性肝炎诊断和治疗共识 (2015) [J].临床肝胆病杂志, 2016, 32 (1) :9-22.
    [18]CZAJA AJ, CARPENTER HA.Autoimmune hepatitis with incidental histologic features of bile duct injury[J].Hepatology, 2001, 34 (4 Pt 1) :659-665.
  • 加载中
计量
  • 文章访问数:  2550
  • HTML全文浏览量:  62
  • PDF下载量:  366
  • 被引次数: 0
出版历程
  • 收稿日期:  2018-09-10
  • 出版日期:  2019-02-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回